Certified by Founder
Lodge
Biotia
start up
United States
- New York, New York
- 24/08/2022
- Series A
- $8,000,000
Biotia is a health tech company spun out of Cornell Tech leveraging next-generation sequencing and artificial intelligence for rapid precision infectious disease discovery. Our software and laboratory technology enable clinicians and researchers to guide patient treatment and improve health outcomes.
- Industry Biotechnology Research
- Website https://www.biotia.io/
- LinkedIn https://www.linkedin.com/company/biotia/
Related People
Niamh B. O'HaraCo Founder
United States -
New York, New York,
CEO and co-founder of Biotia, a startup working with hospitals and researchers to leverage high-complexity tests and artificial intelligence for rapid precision infectious disease discovery to guide patient treatment and improve health outcomes.
Ciphero | $2,500,000 | (Dec 23, 2025)
beycome | $2,500,000 | (Dec 23, 2025)
Givefront | $2,000,000 | (Dec 23, 2025)
StretchSense | $2,300,000 | (Dec 23, 2025)
ZeroPhase | $6,800,000 | (Dec 23, 2025)
Peripheral Labs | $3,600,000 | (Dec 23, 2025)
Ethereal Exploration Guild | $21,000,000 | (Dec 23, 2025)
LatentForce | $1,700,000 | (Dec 23, 2025)
arcads AI | $16,000,000 | (Dec 19, 2025)
Amphix Bio | $12,500,000 | (Dec 19, 2025)
Edison Scientific | $70,000,000 | (Dec 19, 2025)
Thread | $18,000,000 | (Dec 19, 2025)